AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$NTHI

GARNETT KEITHLY purchased $1K of NTHI

GARNETT KEITHLY (CFO) purchased 257 shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $3.89 on 2026-09-14.

Original reporting
SEC EDGAR · GARNETT KEITHLY
Published Sep 16, 2026, 12:44 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 1:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NTHI
Neutral
high confidence
Mentioned
$NTHI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NTHINeutralLow
01

Why it matters

The $1K purchase is routine and unlikely to affect market perception.

02

Market read

Minimal relevance; transaction size is negligible relative to float.

03

What to watch

Potential upcoming corporate actions not disclosed; CFO may be positioning.

Relevance 4/10Novelty 4/10Timing: post‑market 2026‑09‑14

Background

Form 4 filings disclose insider trades; traders watch for material changes in insider holdings.

Company-level read

Ticker impact

$NTHINeutralHigh confidence
Context

CFO Garnett Keithly bought 257 shares for $1,000, increasing his stake to 242,357 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

Purchase size is trivial relative to market cap and total holdings.

Market effects

Sector

None; insider activity does not affect sector trends.

Regional

None; company is US‑listed with limited regional relevance.

Global

None; isolated insider transaction.

Counterpoint

What could challenge this read

Even small insider buys can signal confidence; monitor for future purchases.

Key entities

  • company
    Neonc Technologies Holdings, Inc.

    Issuer of the Form 4 filing.

  • person
    Garnett Keithly

    Chief Financial Officer of Neonc Technologies.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NTHI insider trading history →

Related articles

$NTHIMedAI 8/10

NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress Updated NEO100 Phase 1/2a results and NEO212 Phase 1 data to be presented at the Society for Neuro-Oncology Annual Meeting on November 13 CALABASAS, Calif., Nov.

SEC EDGAR 8-K
$NTHIMedAI 8/10

NeOnc to Present NEO100 and NEO212 Data at Neuro-Oncology Meeting

NeOnc Technologies (NTHI) will present data on its NEO100 and NEO212 programs at the Society for Neuro-Oncology meeting. NEO100 data includes Phase 1/2a study and compassionate use results for recurrent IDH1-mutant astrocytoma. NEO212 data covers Phase 1 safety, pharmacokinetics, and early activity signals in TMZ-resistant recurrent GBM and brain metastases. Both posters are scheduled for November 13, 2026.

tradingview.com
$NTHILowAI 8/10

NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi Treating physicians report that a critically ill three-year-old boy is breathing independently and showing renewed movement following initiation of invest

SEC EDGAR 8-K